Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a significant decrease in short interest in June. As of June 15th, there was short interest totalling 43,000 shares, a decrease of 21.7% from the May 31st total of 54,900 shares. Based on an average trading volume of 15,000 shares, the short-interest ratio is presently 2.9 days.

Shares of BIOAF stock opened at $0.13 on Tuesday. The firm has a fifty day moving average of $0.17 and a 200-day moving average of $0.19. Bioasis Technologies has a 12-month low of $0.13 and a 12-month high of $0.34. The company has a market capitalization of $9.28 million, a price-to-earnings ratio of -2.55 and a beta of 0.32.

Bioasis Technologies (OTCMKTS:BIOAF – Get Rating) last issued its quarterly earnings data on Tuesday, June 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. As a group, sell-side analysts predict that Bioasis Technologies will post -0.03 earnings per share for the current fiscal year.

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases.

Recommended Stories

• Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
• MarketBeat Podcast: Is The Market Near a Bottom, Does it Matter?
• Institutional Support For KB Home Remains High
• Using MarketBeat Market Data Tools To Find Strong Stocks in a Bear Market
• Schnitzer Steel Witnesses A Strong Quarter On The Back Of Strong Domestic Demand
• MarketBeat: Week in Review 6/27 – 7/1

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.